Looking for the phoenix: the current research on radiation countermeasures

References

• Abramson Cancer Center of the University of Pennsylvania. 2020. A phase I blinded, randomized feasibility trial of dietary flaxseed administration in non-small cell lung cancer patients receiving definitive thoracic chemoradiotherapy (Clinical trial registration No. NCT00955942). clinicaltrials.gov.
   Google Scholar
• Ahmed LA. 2019. Nicorandil: a drug with ongoing benefits and different mechanisms in various diseased conditions. Indian J Pharmacol. 51(5):296–301.
   PubMed Web of Science ®Google Scholar
• Ahmed LA, El-Maraghy SA. 2013. Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection. Biochem Pharmacol. 86(9):1301–1310.
   PubMed Web of Science ®Google Scholar
• Ahmed LA, Shehata NI, Abdelkader NF, Khattab MM. 2014. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice. PLoS One. 9(10):e108889.
   PubMed Web of Science ®Google Scholar
• Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F. 2018. N-acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 52(7):751–762.
   PubMed Web of Science ®Google Scholar
• Alok A, Agrawala PK. 2020. Repurposing sodium diclofenac as a radiation countermeasure agent: a cytogenetic study in human peripheral blood lymphocytes. Mutat Res Genet Toxicol Environ Mutagen. 856–857:503220.
   PubMed Web of Science ®Google Scholar
• Anderson PM, Lalla RV. 2020. Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients. 12(6):1675.
   PubMed Web of Science ®Google Scholar
• Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, et al. 2019. Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer. JCO. 37(34):3256–3265.
   PubMed Web of Science ®Google Scholar
• Arora R, Gupta D, Chawla R, Sagar R, Sharma A, Kumar R, Prasad J, Singh S, Samanta N, Sharma RK. 2005. Radioprotection by plant products: present status and future prospects. Phytother Res. 19(1):1–22.
   PubMed Web of Science ®Google Scholar
• Asensio-López MC, Soler F, Pascual-Figal D, Fernández-Belda F, Lax A. 2017. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes. PloS One. 12(2):e0172803.
   PubMed Web of Science ®Google Scholar
• Bailly C. 2019. Irinotecan: 25 years of cancer treatment. Pharmacol Res. 148:104398.
   PubMed Web of Science ®Google Scholar
• Batenburg MCT, van den Bongard H, Kleynen CE, Maarse W, Witkamp A, Ernst M, Doeksen A, van Dalen T, Sier M, Schoenmaeckers EJP, et al. 2020. Assessing the effect of hyperbaric oxygen therapy in breast cancer patients with late radiation toxicity (HONEY trial): a trial protocol using a trial within a cohort design. Trials. 21(1):980.
   PubMed Web of Science ®Google Scholar
• Becker DV. 1983. Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution. Bull N Y Acad Med. 59(10):1003–1008.
   PubMedGoogle Scholar
• Biethahn S, Alves F, Wilde S, Hiddemann W, Spiekermann K. 1999. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Exp Hematol. 27(5):885–894.
   PubMed Web of Science ®Google Scholar
• Bláha M, Vávrová J, Petýrek P, Malý J, Hak J, Slavík Z, Filip S. 1995. DEXRAZOXAN A JEHO MOŽNOSTI OCHRÁNIT LIDSKÝ ORGANISMUS PŘED POŠKOZENÍM ZÁŘENÍM A CYTOSTATIKY. MMSL. 64:57–59.
   Google Scholar
• Bracone F, De Curtis A, Di Castelnuovo A, Pilu R, Boccardi M, Cilla S, Macchia G, Deodato F, Costanzo S, Iacoviello L, et al. 2021. Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial? Clin Nutr Edinb Scotl. 40(4):2068–2077.
   PubMed Web of Science ®Google Scholar
• Bravo L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 56(11):317–333.
   PubMed Web of Science ®Google Scholar
• CADTH. 2015. Eltrombopag Olamine (Revolade), CADTH common drug reviews. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
   Google Scholar
• Caldwell GW. 2015. In silico tools used for compound selection during target-based drug discovery and development. Expert Opin Drug Discov. 10(8):901–923.
   PubMed Web of Science ®Google Scholar
• Catto V, Stronati G, Porro B, Fiorelli S, Ricci V, Vavassori C, Russo E, Guerra F, Gasperetti A, Ribatti V, et al. 2021. Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design. J Interv Card Electrophysiol. 61(3):577–582.
   PubMed Web of Science ®Google Scholar
• Center Eugene Marquis. 2018. Impact of solifenacin succinate for treatment of acute irritative urinary toxicity occurring during radiotherapy of prostatic cancer (Clinical trial registration No. NCT02805452). clinicaltrials.gov.
   Google Scholar
• Center for Biologics Evaluation and Research. 2021. Biologics license applications (BLA) process (CBER) [WWW Document]. FDA. [accessed 2022 Mar 2]. https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/biologics-license-applications-bla-process-cber.
   Google Scholar
• Center for Drug Evaluation and Research 2021. Investigational new drug (IND) application [WWW Document]. FDA. [accessed 2022 Mar 9]. https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application.
   Google Scholar
• Center for Drug Evaluation and Research. 2022. New drug application (NDA) [WWW Document]. FDA. [accessed 2022 Mar 9]. https://www.fda.gov/drugs/types-applications/new-drug-application-nda.
   Google Scholar
• Cervelli T, Panetta D, Navarra T, Gadhiri S, Salvadori P, Galli A, Caramella D, Basta G, Picano E, Del Turco S. 2017. A new natural antioxidant mixture protects against oxidative and DNA damage in endothelial cell exposed to low-dose irradiation. Oxid Med Cell Longev. 2017:1–7.
   Web of Science ®Google Scholar
• Chanez J-F. 2010. The neurogenic component of cutaneous toxicities induced by chemotherapy – new solutions. 3:13–15.
   Google Scholar
• Chang Gung Memorial Hospital. 2021., Radioprotective effect of chinese herbal medicine on ionizing radiation-induced oral mucositis (Clinical trial registration No. NCT05040425). clinicaltrials.gov.
   Google Scholar
• Charalambous DA. 2021. The effectiveness of a thyme and honey spray for the management of oral mucositis and xerostomia in head and neck cancer patients undergoing radiotherapy (Clinical trial registration No. NCT04880148). clinicaltrials.gov.
   Google Scholar
• Charalambous A, Lambrinou E, Katodritis N, Vomvas D, Raftopoulos V, Georgiou M, Paikousis L, Charalambous M. 2017. The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: a feasibility randomized control trial. Eur J Oncol Nurs. 27:1–8.
   PubMed Web of Science ®Google Scholar
• Charalambous M, Raftopoulos V, Paikousis L, Katodritis N, Lambrinou E, Vomvas D, Georgiou M, Charalambous A. 2018. The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: a randomized controlled trial. Eur J Oncol Nurs. 34:89–97.
   PubMed Web of Science ®Google Scholar
• Chen C-H, Kuo M-L, Wang J-L, Liao W-C, Chang L-C, Chan L-P, Lin J. 2015. CCM-AMI, a polyethylene glycol micelle with amifostine, as an acute radiation syndrome protectant in C57BL/6 Mice. Health Phys. 109(3):242–248.
   PubMed Web of Science ®Google Scholar
• Choi J-S, Shin H-S, An H-Y, Kim Y-M, Lim J-Y. 2017. Radioprotective effects of Keratinocyte Growth Factor-1 against irradiation-induced salivary gland hypofunction. Oncotarget. 8(8):13496–13508.
   PubMedGoogle Scholar
• Christofidou-Solomidou M, Pietrofesa R, Arguiri E, McAlexander MA, Witwer KW. 2014. Dietary flaxseed modulates the miRNA profile in irradiated and non-irradiated murine lungs: a novel mechanism of tissue radioprotection by flaxseed. Cancer Biol Ther. 15(7):930–937.
   PubMed Web of Science ®Google Scholar
• Damm R. 2017. Evaluation of the preventive effect of enoxaparin, pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases from colorectal carcinoma, assessed in a prospective randomised trial (Clinical trial registration No. NCT01149304). clinicaltrials.gov.
   Google Scholar
• Delaney G, Jacob S, Featherstone C, Barton M. 2005. The role of radiotherapy in cancer treatment. Cancer. 104(6):1129–1137.
   PubMed Web of Science ®Google Scholar
• Di Franco R, Sammarco E, Calvanese MG, De Natale F, Falivene S, Di Lecce A, Giugliano FM, Murino P, Manzo R, Cappabianca S, et al. 2013. Preventing the acute skin side effects in patients treated with radiotherapy for breast cancer: the use of corneometry in order to evaluate the protective effect of moisturizing creams. Radiat Oncol. 8(1):57.
   PubMedGoogle Scholar
• Donati MB. 2021. Supplementation with dietary anthocyanins and side effects of radiotherapy for breast cancer (Clinical trial registration No. NCT02195960). clinicaltrials.gov.
   Google Scholar
• El-Mahdy MA, Alzarie YA, Hemann C, Badary OA, Nofal S, Zweier JL. 2020. The novel SOD mimetic GC4419 increases cancer cell killing with sensitization to ionizing radiation while protecting normal cells. Free Radic Biol Med. 160:630–642.
   PubMed Web of Science ®Google Scholar
• EMA. 2019. Obtaining an EU marketing authorisation, step-by-step [WWW Document]. EMA. [accessed 2022 May 19]. https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/obtaining-eu-marketing-authorisation-step-step.
   Google Scholar
• EMA. 2020. From lab to patient - timeline [WWW Document]. EMA. [accessed 2022 May 19]. https://www.ema.europa.eu/en/from-lab-to-patient-timeline.
   Google Scholar
• Evans SR. 2010. Clinical trial structures. J Exp Stroke Transl Med. 3(1):8–18.
   PubMedGoogle Scholar
• Faustino PJ, Yang Y, Progar JJ, Brownell CR, Sadrieh N, May JC, Leutzinger E, Place DA, Duffy EP, Houn F, et al. 2008. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue. J Pharm Biomed Anal. 47(1):114–125.
   PubMed Web of Science ®Google Scholar
• FDA. 2002. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Jan 19]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125031.
   Google Scholar
• FDA. 2013. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 3]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021751.
   Google Scholar
• FDA. 2014. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 3]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021626.
   Google Scholar
• FDA. 2016. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 3]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021749. (accessed 3.7.22).
   Google Scholar
• FDA. 2019a. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Jan 19]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020221.
   Google Scholar
• FDA. 2019b. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Feb 22]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125103.
   Google Scholar
• FDA. 2020. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 8]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021518.
   Google Scholar
• FDA. 2021. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Jan 1]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353.
   Google Scholar
• FDA. 2022a. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 10]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022291.
   Google Scholar
• FDA. 2022b. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Feb 25]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&ApplNo=103362.
   Google Scholar
• FDA. 2022c. Drugs@FDA: FDA-approved drugs [WWW Document]. [accessed 2022 Mar 3]. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268.
   Google Scholar
• Filipova A, Marek J, Havelek R, Pejchal J, Jelicova M, Cizkova J, Majorosova M, Muckova L, Kucera T, Prchal L, et al. 2020. Substituted piperazines as novel potential radioprotective agents. Mol Basel Switz. 25:E532.
   Google Scholar
• First Affiliated Hospital of Harbin Medical University. 2021. Kanglaite reduce the toxicity of radiotherapy of head and neck cancer phase II study (Clinical trial registration No. NCT03101514). clinicaltrials.gov.
   Google Scholar
• Friedman H, Ator N, Haigwood N, Newsome W, Allan JS, Golos TG, Kordower JH, Shade RE, Goldberg ME, Bailey MR, et al. 2017. The critical role of nonhuman primates in medical research. Pathog Immun. 2(3):352–365.
   PubMedGoogle Scholar
• Galera Therapeutics, Inc. 2021. A phase 2, randomized, double-blind, placebo-controlled, multi-center trial of the effects of GC4419 on severe oral mucositis in patients receiving cisplatin + intensity-modulated radiation therapy (IMRT) for locally advanced non-metastatic squamous cell carcinoma (SCC) of the oral cavity/oropharynx (Clinical trial registration No. NCT02508389). clinicaltrials.gov.
   Google Scholar
• Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE, Jacobs ER, Medhora M. 2009. Renin-angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol. 75(5):1528–1536.
   PubMed Web of Science ®Google Scholar
• Gluzman-Poltorak Z, Vainstein V, Basile LA. 2015. Association of hematological nadirs and survival in a nonhuman primate model of hematopoietic syndrome of acute radiation syndrome. Radiat Res. 184(2):226–230.
   PubMed Web of Science ®Google Scholar
• Gokhale MS, Vainstein V, Tom J, Thomas S, Lawrence CE, Gluzman-Poltorak Z, Siebers N, Basile LA. 2014. Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects. Exp Hematol Oncol. 3(1):11.
   PubMedGoogle Scholar
• Hahn SM, Krishna MC, DeLuca AM, Coffin D, Mitchell JB. 2000. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med. 28(6):953–958.
   PubMed Web of Science ®Google Scholar
• Havránková R. 2020. Biological effects of ionizing radiation. Cas Lek Cesk. 159(7-8):258–260.
   PubMedGoogle Scholar
• Havránková R, Čuprová J, Falk M, Falková I, Freitinger Skalická Z, Grebenyuk AN, Havránek J, Horáček J, Jebavý L, Kormúth E, et al. 2020. Klinická radiobiologie. 1st ed. A.s., Praha: Grada Publishing.
   Google Scholar
• Heyboer M, Sharma D, Santiago W, McCulloch N. 2017. Hyperbaric oxygen therapy: side effects defined and quantified. Adv Wound Care. 6(6):210–224.
   PubMed Web of Science ®Google Scholar
• Hickling S, Xiang L, Jones KC, Parodi K, Assmann W, Avery S, Hobson M, El Naqa I. 2018. Ionizing radiation-induced acoustics for radiotherapy and diagnostic radiology applications. Med Phys. 45(7):e707–e721.
   PubMed Web of Science ®Google Scholar
• Hoggatt J, Singh P, Stilger KN, Plett PA, Sampson CH, Chua HL, Orschell CM, Pelus LM. 2013. Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation. Blood Cells Mol Dis. 50(3):147–153.
   PubMed Web of Science ®Google Scholar
• Holdiness MR. 1991. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet. 20(2):123–134.
   PubMed Web of Science ®Google Scholar
• Humanetics Corporation. 2020. A phase I/II clinical study evaluating the safety and effectiveness of BIO 300 oral suspension in patients receiving chemoradiation therapy for non-small cell lung cancer (NSCLC) (Clinical trial registration No. NCT02567799). clinicaltrials.gov.
   Google Scholar
• Humanetics Corporation. 2021a. A phase 1 dose escalation trial evaluating the safety and pharmacokinetic profile of BIO 300 oral powder in healthy volunteers (Clinical trial registration No. NCT04650555). clinicaltrials.gov.
   Google Scholar
• Humanetics Corporation. 2021b. [accessed 2022 Aug 9]. https://www.humaneticscorp.com/sept-22-2021.
   Google Scholar
• IAEA. 2018. Medical management of persons internally contaminated with radionuclides in a nuclear or radiological emergency, emergency preparedness and response. Vienna: International Atomic Energy Agency.
   Google Scholar
• Intron Biotechnology, Inc. 2021. A dose blocked-randomized, single-blind, placebo-controlled and dose-escalation phase I clinical trial to evaluate safety, tolerability and pharmacokinetic/pharmacodynamic characteristics of KMRC011 after intramuscular administration in healthy adult volunteers (Clinical trial registration No. NCT03585803). clinicaltrials.gov.
   Google Scholar
• Jacobsen SE, Veiby OP, Smeland EB. 1993. Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med. 178(2):413–418.
   PubMed Web of Science ®Google Scholar
• Jaiswal N, Akhtar J, Singh SP, Ahsan F, Badruddeen . 2019. An overview on genistein and its various formulations. Drug Res. 69(6):305–313.,
   Web of Science ®Google Scholar
• Ji Z. 2019. A phase II trial of capecitabine and irinotecan with or without amifostine in neoadjuvant chemoradiotherapy in locally advanced rectal cancer (Clinical trial registration No. NCT03702985). clinicaltrials.gov.
   Google Scholar
• Kamran MZ, Ranjan A, Kaur N, Sur S, Tandon V. 2016. Radioprotective agents: strategies and translational advances. Med Res Rev. 36(3):461–493.
   PubMed Web of Science ®Google Scholar
• Kang M, Ragan BG, Park J-H. 2008. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 43(2):215–221.
   PubMed Web of Science ®Google Scholar
• Kazzi ZN, Heyl A, Ruprecht J. 2012. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241. Curr Pharm Biotechnol. 13(10):1957–1963.
   PubMed Web of Science ®Google Scholar
• Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, Fakiri EM. 2013. Health benefits of probiotics: a review. ISRN Nutr. 2013:481651.
   PubMedGoogle Scholar
• Kim YS. 2021. Prevention of radiotherapy induced enteropathy by probiotics (PREP trial): a prospective, randomized controlled, double blinded, single center, superiority study (Clinical trial registration No. NCT03978949). clinicaltrials.gov.
   Google Scholar
• Kim YJ, Yu J, Park SP, Lee SH, Kim YS. 2021. Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trial. BMC Cancer. 21(1):1032.
   PubMed Web of Science ®Google Scholar
• King M, Joseph S, Albert A, Thomas TV, Nittala MR, Woods WC, Vijayakumar S, Packianathan S. 2020. Use of amifostine for cytoprotection during radiation therapy: a review. Oncology. 98(2):61–80.
   PubMed Web of Science ®Google Scholar
• Knowles J, Gromo G. 2003. A guide to drug discovery: target selection in drug discovery. Nat Rev Drug Discov. 2(1):63–69.
   PubMed Web of Science ®Google Scholar
• Kreder KJ. 2006. Solifenacin. Urol Clin North Am. 33(4):483–490, ix. ix.
   PubMed Web of Science ®Google Scholar
• Lee H-S, Cho D-W, Han J-S, Han S-C, Woo SK, Jun S-Y, Lee W-J, Yoon S, Pak S-I, Lee S-J, et al. 2020. KMRC011, an agonist of toll-like receptor 5, mitigates irradiation-induced tissue damage and mortality in cynomolgus monkeys. J Immunotoxicol. 17(1):31–42.
   PubMed Web of Science ®Google Scholar
• Li L, Nie X, Zhang P, Huang Y, Ma L, Li F, Yi M, Qin W, Yuan X. 2021. Dexrazoxane ameliorates radiation-induced heart disease in a rat model. Aging. 13(3):3699–3711.
   PubMedGoogle Scholar
• Liesveld J. 2016. Phase I study of eltrombopag for promoting thrombopoiesis in patients undergoing stem cell transplantation after total body irradiation (Clinical trial registration No. NCT00903929). clinicaltrials.gov.
   Google Scholar
• Liesveld JL, Phillips GL, Becker M, Constine LS, Friedberg J, Andolina JR, Milner LA, DeBolt J, Smudzin T, Hyrien O, et al. 2013. A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 19(12):1745–1752.
   PubMed Web of Science ®Google Scholar
• Lin EC. 2010. Radiation risk from medical imaging. Mayo Clin Proc. 85(12):1142–1146; quiz 1146. quiz 1146.
   PubMed Web of Science ®Google Scholar
• Liu Q, Jiang B, Jiang L-P, Wu Y, Wang X-G, Zhao F-L, Fu B-H, Istvan T, Jiang E. 2008. Clinical report of three cases of acute radiation sickness from a (60)Co radiation accident in Henan Province in China. JRR. 49(1):63–69.
   PubMed Web of Science ®Google Scholar
• Liu H, Li L, Zou J, Zhou T, Wang B, Sun H, Yu S. 2019. Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis. BMC Complement Altern Med. 19(1):267.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, Sun S-C. 2017. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2:17023–17023.
   PubMed Web of Science ®Google Scholar
• Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK. 2007. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys. 69(4):1008–1017.,
   PubMed Web of Science ®Google Scholar
• Marek J, Tichy A, Havelek R, Seifrtova M, Filipova A, Andrejsova L, Kucera T, Prchal L, Muckova L, Rezacova M, et al. 2020. A novel class of small molecule inhibitors with radioprotective properties. Eur J Med Chem. 187:111606.
   PubMed Web of Science ®Google Scholar
• Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. 1990. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg. 160(5):519–524.
   PubMed Web of Science ®Google Scholar
• Matrix Biomed, Inc. 2021. A double blind, placebo controlled dose range finding study to assess the safety, pharmacokinetics, and efficacy of tempol for the reduction of severe mucositis in head and neck cancer patients undergoing combined radio- and chemotherapy (Clinical trial registration No. NCT03480971). clinicaltrials.gov.
   Google Scholar
• McDonnell AM, Lenz KL. 2007. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis. Ann Pharmacother. 41(1):86–94.
   PubMed Web of Science ®Google Scholar
• McMaster University. 2021. Multi-nutrient supplement for radio-protection (Clinical trial registration No. NCT04781868). clinicaltrials.gov.
   Google Scholar
• Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. 2006. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. J Clin Oncol. 24(25):4069–4077.
   PubMed Web of Science ®Google Scholar
• Metheny L, Eid S, Lingas K, Ofir R, Pinzur L, Meyerson H, Lazarus HM, Huang AY. 2018. Posttransplant intramuscular injection of PLX-R18 mesenchymal-like adherent stromal cells improves human hematopoietic engraftment in A murine transplant model. Front Med. 5:37.
   Web of Science ®Google Scholar
• Mitchell JB, Anver MR, Sowers AL, Rosenberg PS, Figueroa M, Thetford A, Krishna MC, Albert PS, Cook JA. 2012. The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res. 72(18):4846–4855.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Mukund V, Mukund D, Sharma V, Mannarapu M, Alam A. 2017. Genistein: its role in metabolic diseases and cancer. Crit Rev Oncol Hematol. 119:13–22.
   PubMed Web of Science ®Google Scholar
• Nagayama H, Misawa K, Tanaka H, Ooi J, Iseki T, Tojo A, Tani K, Yamada Y, Kodo H, Takahashi TA, et al. 2002. Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim. Bone Marrow Transplant. 29(3):197–204.
   PubMed Web of Science ®Google Scholar
• Neumedicines Inc. 2018. A phase 2 single-dose, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HemaMaxTM (rHuIL-12) in healthy subjects (Clinical trial registration No. NCT02343133). clinicaltrials.gov.
   Google Scholar
• Office of the Commissioner. 2019. Step 3: clinical research. FDA.
   Google Scholar
• Office of the Commissioner. 2021a. Animal rule information. FDA.
   Google Scholar
• Office of the Commissioner. 2021b. Radiological and nuclear emergency preparedness information from FDA. FDA.
   Google Scholar
• Ofir R, Sher N. 2017. CELL THERAPY - PLX-R18: cell therapy for treatment of acute radiation syndrome & bone marrow failure diseases. Drug Dev. Deliv. [accessed 2022 Feb 18]. https://drug-dev.com/cell-therapy-plx-r18-cell-therapy-for-treatment-of-acute-radiation-syndrome-bone-marrow-failure-diseases/.
   Google Scholar
• Original BioMedicals Co. Ltd. 2015., A phase I study to evaluate the safety and pharmacokinetics of RadProtect® in healthy volunteers (Clinical trial registration No. NCT02587442). clinicaltrials.gov.
   Google Scholar
• Österreicher J, Vávrová J, Knížek J, Petýrek P. 1999. VLIV LÁTEK S RADIOPROTEKTIVNÍM ÚČINKEM NA VZNIK A ROZVOJ RADIAČNÍ PNEUMONITIDY. MMSL. 68:143–148.
   Google Scholar
• Pluristem Ltd. 2020. Open-label phase I study to evaluate the safety of PLX-R18 for the post-exposure prevention (PEP) or treatment of hematopoietic syndrome of acute radiation syndrome (HS-ARS) (Clinical trial registration No. NCT03797040). clinicaltrials.gov.
   Google Scholar
• PubChem. 2022. Nicorandil [WWW Document]. [accessed 2022 Mar 15]. https://pubchem.ncbi.nlm.nih.gov/compound/47528.
   Google Scholar
• Radiation Therapy Oncology Group. 2020. A randomized phase III trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiotherapy for carcinoma of the head and neck (Clinical trial registration No. NCT00004917). clinicaltrials.gov.
   Google Scholar
• Rafehi H, Orlowski C, Georgiadis GT, Ververis K, El-Osta A, Karagiannis TC. 2011. Clonogenic assay: adherent cells. J Vis Exp JoVE. 49:2573.
   PubMedGoogle Scholar
• Raj S, Manchanda R, Bhandari M, Alam MS. 2022. Review on natural bioactive products as radioprotective therapeutics: present & past perspective. Curr Pharm Biotechnol. 23(14):1721–1738.
   PubMed Web of Science ®Google Scholar
• Rasey JS. 1999. Amifostine. Cancer Biother Radiopharm. 14(5):331–335.
   PubMed Web of Science ®Google Scholar
• Rosen E, Fatanmi OO, Wise SY, Rao VA, Singh VK. 2022. Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice. Sci Rep. 12(1):3387.
   PubMed Web of Science ®Google Scholar
• Ryan JL, Krishnan S, Movsas B, Coleman CN, Vikram B, Yoo SS. 2011. Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors. Radiat Res. 176(5):688–691.
   PubMed Web of Science ®Google Scholar
• Saaya FM, Katsube T, Xie Y, Tanaka K, Fujita K, Wang B. 2017. Research and development of radioprotective agents: a mini-review. Int J Radiol. 4(2):128–138.
   Google Scholar
• Schulz KF, Grimes DA. 2002. Blinding in randomised trials: hiding who got what. Lancet Lond Engl. 359(9307):696–700.
   PubMed Web of Science ®Google Scholar
• Seidensticker M, Seidensticker R, Damm R, Mohnike K, Pech M, Sangro B, Hass P, Wust P, Kropf S, Gademann G, et al. 2014. Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity. PLoS One. 9(11):e112731.
   PubMed Web of Science ®Google Scholar
• Singh VK, Beattie LA, Seed TM. 2013. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures. J Radiat Res. 54(6):973–988.
   PubMed Web of Science ®Google Scholar
• Singh VK, Garcia M, Seed TM. 2017. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status. Int J Radiat Biol. 93(9):870–884.
   PubMed Web of Science ®Google Scholar
• Singh VK, Hanlon BK, Santiago PT, Seed TM. 2017. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use. Int J Radiat Biol. 93:885–906.
   PubMed Web of Science ®Google Scholar
• Singh VK, Hauer-Jensen M. 2016. γ-Tocotrienol as a promising countermeasure for acute radiation syndrome: current status. IJMS. 17(5):663.
   Google Scholar
• Singh VK, Seed TM. 2017. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 93(9):851–869.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. 2019. The efficacy and safety of amifostine for the acute radiation syndrome. Expert Opin Drug Saf. 18(11):1077–1090.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. 2020a. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems. Expert Opin Pharmacother. 21(3):317–337.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. 2020b. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure. Expert Opin Investig Drugs. 29(5):429–441.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. 2021a. Repurposing pharmaceuticals previously approved by regulatory agencies to medically counter injuries arising either early or late following radiation exposure. Front Pharmacol. 12:624844.
   PubMed Web of Science ®Google Scholar
• Singh VK, Seed TM. 2021b. Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond. Int J Radiat Biol. 97(11):1526–1547.
   PubMed Web of Science ®Google Scholar
• Song L, Ma L, Cong F, Shen X, Jing P, Ying X, Zhou H, Jiang J, Fu Y, Yan H. 2015. Radioprotective effects of genistein on HL-7702 cells via the inhibition of apoptosis and DNA damage. Cancer Lett. 366(1):100–111.
   PubMed Web of Science ®Google Scholar
• State Institute for Drug Control 2021., METALCAPTASE, 300MG TBL ENT 50, State Institute for Drug Control [WWW Document]. [accessed 2022 Jul 20]. https://www.sukl.eu/modules/medication/detail.php?code=0066753&tab=texts&lang=2.
   Google Scholar
• Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, Dynan WS, Fike JR, Grdina DJ, Greenberger JS, et al. 2004. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res. 162(6):711–728.
   PubMed Web of Science ®Google Scholar
• Teguh DN, Bol Raap R, Struikmans H, Verhoef C, Koppert LB, Koole A, Huang Y, van Hulst RA. 2016. Hyperbaric oxygen therapy for late radiation-induced tissue toxicity: prospectively patient-reported outcome measures in breast cancer patients. Radiat Oncol. 11(1):130.
   PubMedGoogle Scholar
• Tian T, Zhao Y, Yang Y, Wang T, Jin S, Guo J, Liu Z. 2020. The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. Am J Cancer Res. 10(11):3508–3531.
   PubMed Web of Science ®Google Scholar
• Tondo C. 2021. Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: n-acetylcysteine protection against radiation induced cellular damagE (CARAPACE Study) (Clinical trial registration No. NCT04154982). clinicaltrials.gov.
   Google Scholar
• Toon OB, Bardeen CG, Robock A, Xia L, Kristensen H, McKinzie M, Peterson RJ, Harrison CS, Lovenduski NS, Turco RP. 2019. Rapidly expanding nuclear arsenals in Pakistan and India portend regional and global catastrophe. Sci Adv. 5(10):eaay5478.
   PubMed Web of Science ®Google Scholar
• Umscheid CA, Margolis DJ, Grossman CE. 2011. Key concepts of clinical trials: a narrative review. Postgrad Med. 123(5):194–204.
   PubMed Web of Science ®Google Scholar
• UNC Lineberger Comprehensive Cancer Center. 2021. LCCC2032: the effects of short chain fatty acid supplementation on the quality of life and treatment-related toxicities in subjects receiving abdominopelvic radiotherapy: a randomized controlled study (Clinical trial registration No. NCT04700527). clinicaltrials.gov.
   Google Scholar
• University Hospital, Limoges. 2015. Skin protection during radiotherapy in patients with breast cancer: a comparative study of Evoskin® Verus Trixéra® (Clinical trial registration No. NCT02334345). clinicaltrials.gov.
   Google Scholar
• University of Arkansas. 2019., Glutamine for the prevention of radiation toxicity in subjects undergoing breast conserving therapy (Clinical trial registration No. study/NCT02012608). clinicaltrials.gov.
   Google Scholar
• VA Office of Research and Development. 2019. Mitigation of radiation pneumonitis and fibrosis (Clinical trial registration No. NCT01754909). clinicaltrials.gov.
   Google Scholar
• Vasin MV, Gan’shina TS, Mirzoyan RS, Semenova LA, Koroleva LV, Afanas’ev RV, Ushakov IB. 2018. Mitigating effect of nitrates (monizol) on pharmacodynamic shifts in the cardiovascular system caused by radioprotector indralin. Bull Exp Biol Med. 165(3):364–367.,
   PubMed Web of Science ®Google Scholar
• Vasin MV, Semenov LF, Suvorov NN, Antipov VV, Ushakov IB, Ilyin LA, Lapin BA. 2014. Protective effect and the therapeutic index of indralin in juvenile rhesus monkeys. J Radiat Res. 55(6):1048–1055.
   PubMed Web of Science ®Google Scholar
• Verkooijen HM. 2019. The effect of hyperbaric oxygen therapy on breast cancer patients with late radiation toxicity (Clinical trial registration No. NCT04193722). clinicaltrials.gov.
   Google Scholar
• Wang B, Nichol JL, Sullivan JT. 2004. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther. 76(6):628–638.
   PubMed Web of Science ®Google Scholar
• Wang X, Ren J, Liang X, He P. 2021. Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation. Hematology. 26(1):950–955.
   PubMed Web of Science ®Google Scholar
• Ward WF, Molteni A, Ts’ao C-h, Hinz JM. 1990. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol. 19(6):1405–1409.,
   PubMed Web of Science ®Google Scholar
• Ward WF, Molteni A, Ts’ao C-H, Kim YT, Hinz JM. 1992. Radiation pneumotoxicity in rats: Modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol. 22:623–625.
   PubMedGoogle Scholar
• Weiss JF, Landauer MR. 2009. History and development of radiation-protective agents. Int J Radiat Biol. 85(7):539–573.
   PubMed Web of Science ®Google Scholar
• Woo J-H, Dapeng L, Dapeng L, Orita H, Coulter J, Tully E, Kwon TK, Xu S, Gabrielson E. 2007. Coix seed extract, A commonly used treatment for cancer in china, inhibits NFκB and protein kinase C signaling. Cancer Biol Ther. 6(12):2005–2011.
   PubMed Web of Science ®Google Scholar
• Wu S-Y. 2016. Mitigation of radiation pneumonitis, fibrosis and heart toxicity with nicorandil in lung cancer patients (Clinical trial registration No. NCT02809456). clinicaltrials.gov.
   Google Scholar
• Yan H, Jiang J, Du A, Gao J, Zhang D, Song L. 2020. Genistein enhances radiosensitivity of human hepatocellular carcinoma cells by inducing G2/M arrest and apoptosis. Radiat Res. 193(3):286–300.
   PubMed Web of Science ®Google Scholar
• Yang E, Choi H, Park J-S, Noh Y-W, Choi C-M, Lee W-J, Ko J-W, Kim J. 2021. A first-in-human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics. Clin Transl Sci. 14(6):2161–2170.
   PubMed Web of Science ®Google Scholar
• Yang Y, Faustino PJ, Progar JJ, Brownell CR, Sadrieh N, May JC, Leutzinger E, Place DA, Duffy EP, Yu LX, et al. 2008. Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue. Int J Pharm. 353(1-2):187–194.
   PubMedGoogle Scholar
• Yang B-B, Kido A. 2011. Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clin Pharmacokinet. 50(5):295–306.
   PubMed Web of Science ®Google Scholar
• Yang H, Lu Z, Huo C, Chen Y, Cao H, Xie P, Zhou H, Liu D, Liu J, Yu L. 2019. Liang-Ge-San, a classic traditional Chinese medicine formula, attenuates lipopolysaccharide-induced acute lung injury through up-regulating miR-21. Front Pharmacol. 10:1332.
   PubMed Web of Science ®Google Scholar